Chantix
Product Images NDC 50090-4481

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 50090-4481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical Structure (Chantix 01)
Chemical structure diagram of the active ingredient in CHANTIX. The image shows the molecular framework including multiple ring systems and functional groups with hydroxyl, carboxyl, and nitrogen heterocycles.*
FDA Label Image

Figure 1 (Chantix 02)

Figure 1 (Chantix 02)
A bar chart comparing the effects of CHANTIX at various doses versus placebo and bupropion in multiple clinical studies. The vertical axis measures percentage outcomes up to 60%, while each cluster of bars represents different study results. CHANTIX and comparator drugs are shown with error bars indicating variability in response.*
FDA Label Image

Figure 2 (Chantix 03)

Figure 2 (Chantix 03)
A bar chart comparing percentage values across multiple studies (Study 2 to Study 5) for CHANTIX at various dosages and control/placebo groups. Each study section shows bars representing different treatments including CHANTIX 0.5 mg BID, CHANTIX 1.0 mg BID, CHANTIX flexible, Bupropion SR 150 mg BID, and placebo. The vertical axis is marked by percentage values up to 35%, with error bars visible on each bar indicating variability or confidence intervals.*
FDA Label Image

Figure 3 (Chantix 04)

Figure 3 (Chantix 04)
A line graph comparing the percentage of continuous abstinent individuals over time between CHANTIX 1.0 mg BID and placebo groups. The x-axis represents nontreatment follow-up in weeks, and the y-axis shows percentage continuous abstinent, with CHANTIX showing higher abstinence rates than placebo throughout the follow-up period.*
FDA Label Image

Logo (Chantix 05)

FDA Label Image

Logo (Chantix 06)

FDA Label Image

Label Image (Lbl500904481)

Label Image (Lbl500904481)
CHANTIX 0.5 MG tablet packaging label from A-S Medication Solutions. The label includes NDC 50090-4481-0, a count of 56 tablets, and storage instructions to store at 77 degrees Fahrenheit. It also lists the manufacturer as Pfizer Inc and includes warnings about varenicline and free base content.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.